Meng Luo

Dr. Meng Luo


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
LZLijun Zhu
Lijun Zhu
MXMingmei Xiao
Mingmei Xiao
JLJigang Luo
Jigang Luo
SLShijie Li
Shijie Li
WLWenting Liu
Wenting Liu
MLMeng Luo
Meng Luo

13 September 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YCYao Chen
Yao Chen
JDJindian Dong
Jindian Dong
WLWenting Liu
Wenting Liu
QXQilian Xia
Qilian Xia
TLTao Liu
Tao Liu
SLShijie Li
Shijie Li

1 October 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MXMingmei Xiao
Mingmei Xiao
JZJiuhua Zhang
Jiuhua Zhang
JWJiajin Wu
Jiajin Wu
NYNing Yuan
Ning Yuan
TLTao Liu
Tao Liu
MLMeng Luo
Meng Luo

29 June 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MLMeng Luo
Meng Luo
TYTian Yu
Tian Yu
CGChengcheng Ge
Chengcheng Ge
XSXiuting Shen
Xiuting Shen
PLPan Li
Pan Li
SLShijie Li
Shijie Li

2 March 2022 in Food & Function
Verified
Journal Article
Open access
PDF file
MLMeng Luo
Meng Luo
MZMengru Zhu
Mengru Zhu
JWJun Wu
Jun Wu
TYTian Yu
Tian Yu
YCYao Chen
Yao Chen
NXNenggui Xu
Nenggui Xu
Correction for ‘Fucoidans from Cucumaria frondosa ameliorate renal interstitial fibrosis via inhibition of the PI3K/Akt/NF-κB signaling pathway’ by Zhuoyue Song et al., Food Funct., 2022, 13, 1168–1179, DOI: 10.1039/D1FO03067A.

7 August 2026 in Medicine
Verified
Journal Article
Open access
MLMeng Luo
Meng Luo
CGChengcheng Ge
Chengcheng Ge
JCJie Chen
Jie Chen
JDJindian Dong
Jindian Dong
CLChang Liu
Chang Liu
HLHongyi Li
Hongyi Li
Rudijinniuding (RDJND), a proprietary formulation developed by Guangdong Provincial Hospital of Chinese Medicine, has demonstrated favorable anti-inflammatory and analgesic effects when applied in herpes zoster (HZ). However, its specific bioactive composition and underlying mechanisms remain unclear. The major constituents of RDJND were identified using ultra‑performance liquid chromatography with quadrupole/time‑of‑flight mass spectrometry. Network pharmacology was employed to screen for potential targets against HZ. Furthermore, molecular docking and molecular dynamics simulations were conducted to systematically elucidate the mechanism of action of RDJND against HZ. A total of 35 components were identified in RDJND, primarily alkaloids, phenolic acids, flavonoids, and coumarins. Network pharmacology analysis suggested that the effects of RDJND on HZ might involve the regulation of the phosphoinositide 3‑kinase/protein kinase B and mitogen‑activated protein kinase signaling pathways, as well as biological responses such as oxidative stress and responses to bacteria-derived molecules. Molecular docking and dynamics simulations further confirmed that the relevant complexes exhibited strong binding affinity and stability. This study clarified the bioactive composition of RDJND and its comprehensive pharmacological effects in the treatment of HZ through multi-target and multi-pathway mechanisms. These findings provide a theoretical basis for the clinical application of RDJND in HZ treatment and lay the groundwork for subsequent research and development efforts.